Aspiriant LLC’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.73M | Sell |
18,548
-2,217
| -11% | -$360K | 0.08% | 93 |
|
|
2025
Q4 | $4.05M | Buy |
20,765
+937
| +5% | +$223K | 0.12% | 81 |
|
|
2025
Q3 | $5.58M | Sell |
19,828
-166
| -0.8% | -$42.3K | 0.17% | 60 |
|
|
2025
Q2 | $4.37M | Sell |
19,994
-72
| -0.4% | -$11.6K | 0.14% | 68 |
|
|
2025
Q1 | $2.81M | Buy |
20,066
+305
| +2% | +$49.7K | 0.1% | 79 |
|
|
2024
Q4 | $3.29M | Sell |
19,761
-228
| -1% | -$40.5K | 0.12% | 72 |
|
|
2024
Q3 | $3.41M | Sell |
19,989
-50
| -0.2% | -$7.24K | 0.13% | 70 |
|
|
2024
Q2 | $2.83M | Sell |
20,039
-827
| -4% | -$103K | 0.12% | 79 |
|
|
2024
Q1 | $2.62M | Sell |
20,866
-1,159
| -5% | -$133K | 0.11% | 84 |
|
|
2023
Q4 | $2.32M | Sell |
22,025
-386
| -2% | -$42.1K | 0.1% | 89 |
|
|
2023
Q3 | $2.37M | Buy |
22,411
+1,386
| +7% | +$160K | 0.12% | 81 |
|
|
2023
Q2 | $2.5M | Buy |
21,025
+398
| +2% | +$41.1K | 0.13% | 79 |
|
|
2023
Q1 | $1.92M | Buy |
20,627
+92
| +0.4% | +$8.07K | 0.1% | 90 |
|
|
2022
Q4 | $1.68M | Sell |
20,535
-34
| -0.2% | -$2.58K | 0.09% | 96 |
|
|
2022
Q3 | $1.25M | Buy |
20,569
+775
| +4% | +$56.7K | 0.06% | 101 |
|
|
2022
Q2 | $1.38M | Buy |
19,794
+140
| +0.7% | +$10.2K | 0.07% | 99 |
|
|
2022
Q1 | $1.63M | Sell |
19,654
-20,406
| -51% | -$1.65M | 0.09% | 97 |
|
|
2021
Q4 | $3.49M | Buy |
40,060
+24,750
| +162% | +$2.32M | 0.19% | 62 |
|
|
2021
Q3 | $1.33M | Buy |
15,310
+106
| +0.7% | +$9.36K | 0.08% | 99 |
|
|
2021
Q2 | $1.18M | Sell |
15,204
-216
| -1% | -$16.9K | 0.07% | 104 |
|
|
2021
Q1 | $1.08M | Sell |
15,420
-538
| -3% | -$34.8K | 0.07% | 99 |
|
|
2020
Q4 | $1.03M | Buy |
15,958
+894
| +6% | +$53.2K | 0.07% | 96 |
|
|
2020
Q3 | $901K | Sell |
15,064
-911
| -6% | -$51.8K | 0.07% | 105 |
|
|
2020
Q2 | $885K | Buy |
15,975
+1,335
| +9% | +$70.7K | 0.08% | 90 |
|
|
2020
Q1 | $706K | Hold |
14,640
| – | – | 0.07% | 101 |
|
|
2019
Q4 | $775K | Buy |
14,640
+356
| +2% | +$19.6K | 0.07% | 108 |
|
|
2019
Q3 | $789K | Sell |
14,284
-157
| -1% | -$8.67K | 0.07% | 117 |
|
|
2019
Q2 | $822K | Sell |
14,441
-1,137
| -7% | -$61.5K | 0.07% | 125 |
|
|
2019
Q1 | $833K | Sell |
15,578
-1,735
| -10% | -$88.4K | 0.07% | 123 |
|
|
2018
Q4 | $782K | Sell |
17,313
-2,489
| -13% | -$119K | 0.06% | 119 |
|
|
2018
Q3 | $1.02M | Sell |
19,802
-5,189
| -21% | -$252K | 0.09% | 105 |
|
|
2018
Q2 | $1.1M | Buy |
24,991
+5,719
| +30% | +$263K | 0.09% | 103 |
|
|
2018
Q1 | $882K | Buy |
+19,272
| New | +$958K | 0.08% | 113 |
|
|
2017
Q4 | – | Sell |
-19,466
| Closed | -$941K | – | 144 |
|
|
2017
Q3 | $941K | Buy |
19,466
+1,294
| +7% | +$64.4K | 0.08% | 111 |
|
|
2017
Q2 | $911K | Buy |
18,172
+12,601
| +226% | +$574K | 0.08% | 117 |
|
|
2017
Q1 | $249K | Buy |
+5,571
| New | +$232K | 0.02% | 187 |
|
|
2016
Q3 | – | Sell |
-63,418
| Closed | -$2.56M | – | 197 |
|
|
2016
Q2 | $2.56M | Buy |
+63,418
| New | +$2.53M | 0.24% | 66 |
|
Other funds holding ORCL
VCM
VPM
Aspiriant LLC's ORCL Position: Q1 2026 in Review
Aspiriant LLC reduced its Oracle (ORCL) stake by 11% in Q1 2026, selling an estimated $360K and leaving 18,548 shares worth $2.73M. The position accounts for 0.08% of the portfolio, ranked #93.
Aspiriant LLC first reported a position in ORCL in Q2 2016 and has held it in 37 quarters since. The position peaked at $5.58M in Q3 2025. 3,471 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.
- Aspiriant LLC held 18,548 shares of Oracle worth $2.73M as of Q1 2026.
- Aspiriant LLC sold 2,217 Oracle shares in Q1 2026, an estimated $360K.
- Oracle made up 0.08% of Aspiriant LLC's portfolio in Q1 2026, its #93 holding.
- Aspiriant LLC first reported a position in Oracle in Q2 2016 and has held it in 37 quarters since.
- Aspiriant LLC's Oracle position peaked at $5.58M in Q3 2025.
- 3,471 funds tracked by Wall St. Rank held Oracle as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.